DASILVA-JARDINE, PAUL,DE HAARD, HANS,LANDRO, JAMES A.
申请号：
CA3030099
公开号：
CA3030099A1
申请日:
2017.07.07
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
